Cargando…

Incident systemic rheumatic disease following COVID-19

Detalles Bibliográficos
Autores principales:	Hsu, Tiffany Y-T, D'Silva, Kristin M, Patel, Naomi J, Fu, Xiaoqing, Wallace, Zachary S, Sparks, Jeffrey A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023691/ https://www.ncbi.nlm.nih.gov/pubmed/33842894 http://dx.doi.org/10.1016/S2665-9913(21)00106-5

Ejemplares similares

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
por: D’Silva, Kristin M, et al.
Publicado: (2020)

DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
por: Di Iorio, Michael, et al.
Publicado: (2022)

Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
por: Hsu, Tiffany Y-T, et al.
Publicado: (2021)

COVID-19 and Disease-Modifying Anti-rheumatic Drugs
por: D’Silva, Kristin M., et al.
Publicado: (2021)

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study
por: Di Iorio, Michael, et al.
Publicado: (2022)

COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study
por: Patel, Naomi J., et al.
Publicado: (2021)

Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
por: Patel, Naomi J., et al.
Publicado: (2021)

Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
por: Patel, Naomi J., et al.
Publicado: (2023)

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
por: Kawano, Yumeko, et al.
Publicado: (2022)

Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
por: Jorge, April, et al.
Publicado: (2021)

Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
por: Vanni, Kathleen MM, et al.
Publicado: (2022)

Rheumatic Swellings Following Antitoxin Injections
por: Metcalfe, J. A.
Publicado: (1902)

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
por: Qian, Grace, et al.
Publicado: (2023)

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
por: Qian, Grace, et al.
Publicado: (2022)

Rheumatism
por: Banerjee, R. P.
Publicado: (1907)

Rheumatism and Dysentery
por: Deb, Taraknath
Publicado: (1901)

Muscular Rheumatism
Publicado: (1868)

404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients
por: Herman, Jonathan, et al.
Publicado: (2023)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Dr. Maclagan on Rheumatism
por: Clarke, J. Tertius
Publicado: (1896)

The Misuse of the Term "Rheumatism"
por: Clarke, J. T.
Publicado: (1907)

Rheumatic Fever in the Tropics
por: Clark, J. T.
Publicado: (1931)

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
por: Georgiev, Tsvetoslav
Publicado: (2020)

Rheumatism after Rat-Bite
por: Savant, S. V.
Publicado: (1913)

Prevalence of Rheumatic Heart Disease
por: Ceylan, Özben, et al.
Publicado: (2017)

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence
por: Venerito, Vincenzo, et al.
Publicado: (2020)

Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic
por: Masini, Francesco, et al.
Publicado: (2020)

Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic
por: Kim, Hyun-Sook, et al.
Publicado: (2020)

Clinical Evidence of Rheumatic Fever in the Punjab
por: McRobert, George R.
Publicado: (1935)

The Treatment of Rheumatism by Sodium Salicylate Injections
por: Ram, Raja
Publicado: (1923)

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
por: Schreiber, Karen, et al.
Publicado: (2020)

Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective
por: Tariq, Javeria, et al.
Publicado: (2021)

The Syphilitic Factor Is So-Called Chronic Rheumatism
por: Calvert, J. T.
Publicado: (1918)

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic
por: Mukusheva, Zaure, et al.
Publicado: (2020)

The Effect of Early Tonsillectomy on the Incidence of Acute Rheumatism
por: Wallace, H. L., et al.
Publicado: (1936)

COVID-19 encounters reported to the Canadian Anesthesia Incident Reporting System (CAIRS)
por: Beattie, W. Scott, et al.
Publicado: (2021)

Incidence of autism in high risk neonatal follow up
por: Al-Mendalawi, Mahmood D.
Publicado: (2016)

Employment of the Salicylate of Soda for Rheumatism, Gout, Etc., in Scotland, France and Germany
por: Caldwell, W. S.
Publicado: (1878)

Onychomadesis Following Varicella Infection: Is it a Mere Co-incidence?
por: Podder, Indrashis, et al.
Publicado: (2015)

Correspondence on ‘2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringer et al
por: Cui, Ran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c0frjsi06e8otms26epcpglt5s